Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: Elevated normal levels in infancy and age-specific analysis in atopic dermatitis

Pediatric Allergy and Immunology

Volumn 20, Issue 7, 2009, Pages 633-641

  Fujisawa, Takao ^a   Nagao, Mizuho ^a   Hiraguchi, Yukiko ^a   Katsumata, Hajime ^a   Nishimori, Hisashi ^a   Iguchi, Kosei ^a   Kato, Yoshiko ^a   Higashiura, Masahito ^c   Ogawauchi, Izumi ^c   Tamaki, Kunihiko ^b  

^a MIE NATIONAL HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SHIONOGI AND CO LTD   (Japan)

Author keywords

Atopic dermatitis; Infants; IP 10 CXCL10; TARC CCL17; Th 1 Th 2 balance

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON INDUCIBLE PROTEIN 10; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ARTICLE; ATOPIC DERMATITIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HUMAN; INFANCY; INFANT; MALE; NORMAL VALUE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

AGE FACTORS; BIOLOGICAL MARKERS; CHEMOKINE CCL17; CHEMOKINE CXCL10; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFANT; INFANT, NEWBORN; SEVERITY OF ILLNESS INDEX; TH1 CELLS; TH2 CELLS; THYMUS GLAND;

EID: 70349944005     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2009.00851.x     Document Type: Article

References (32)

1. Vestergaard C, Yoneyama H, Murai M, et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999 : 104 : 1097 1105.
2. Vestergaard C, Bang K, Gesser B, et al. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 2000 : 115 : 640 646.
3. Kakinuma T, Nakamura K, Wakugawa M, et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001 : 107 : 535 541.
4. Fujisawa T, Fujisawa R, Kato Y, et al. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation- regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 2002 : 110 : 139 146.
5. Hijnen D, De Bruin-Weller M, Oosting B, et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004 : 113 : 334 340.
6. Prescott SL, Macaubas C, Holt BJ, et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 1998 : 160 : 4730 4737.
7. Morita A, Kikuoka S, Horikawa T, et al. Evaluation of human thymus and activation-regulated chemokine concentrations in blood using a new sandwich ELISA based on monoclonal antibodies. Clin Chim Acta 2002 : 322 : 67 75.
8. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980 : 92 : 44 7.
9. The European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993 : 186 : 23 31.
10. Kato K, Fukui H, Hamaguchi Y, et al. Enzyme-linked immunoassay: conjugation of the Fab' fragment of rabbit IgG with beta-D-galactosidase from E. coli and its use for immunoassay. J Immunol 1976 : 116 : 1554 1560.
11. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993 : 39 : 561 577.
12. Morita A, Shimosako K, Kikuoka S, et al. Development of a sensitive enzyme-linked immunosorbent assay for eotaxin and measurement of its levels in human blood. J Immunol Methods 1999 : 226 : 159 167.
13. Yoshie O, Imai T, Nomiyama H. Chemokines in immunity. Adv Immunol 2001 : 78 : 57 110.
14. IUIS/WHO subcommittee on chemokine nomenclature. Chemokine/chemokine receptor nomenclature. Cytokine 2003 : 21 : 48 9.
15. Imai T, Yoshida T, Baba M, et al. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 1996 : 271 : 21514 21521.
16. Imai T, Baba M, Nishimura M, et al. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997 : 272 : 15036 15042.
17. Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen- presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999 : 11 : 81 8.
18. Campbell JJ, Haraldsen G, Pan J, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999 : 400 : 776 780.
19. Sekiya T, Miyamasu M, Imanishi M, et al. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 2000 : 165 : 2205 2213.
20. Jahnz-Rozyk K, Targowski T, Paluchowska E, et al. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005 : 60 : 685 688.
21. Leung TF, Ma KC, Hon KL, et al. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children. Pediatr Allergy Immunol 2003 : 14 : 296 301.
22. Mostafa GA, Tomoum HY, Salem SA, et al. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children. Pediatr Allergy Immunol 2008.
23. Nakazato J, Kishida M, Kuroiwa R, et al. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Pediatr Allergy Immunol 2008.
24. Von Mutius E, Martinez FD, Fritzsch C, et al. Prevalence of asthma and atopy in two areas of West and East Germany. Am J Respir Crit Care Med 1994 : 149 : 358 364.
25. Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001 : 358 : 1129 1133.
26. Zhang G, Spickett J, Lee AH, et al. Household hygiene practices in relation to dampness at home and current wheezing and rhino-conjunctivitis among school age children. Pediatr Allergy Immunol 2005 : 16 : 587 592.
27. Duse M, Donato F, Porteri V, et al. High prevalence of atopy, but not of asthma, among children in an industrialized area in North Italy: the role of familial and environmental factors - a population-based study. Pediatr Allergy Immunol 2007 : 18 : 201 208.
28. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989 : 299 : 1259 1260.
29. Romagnani S. Coming back to a missing immune deviation as the main explanatory mechanism for the hygiene hypothesis. J Allergy Clin Immunol 2007 : 119 : 1511 1513.
30. Mitsui H, Watanabe T, Saeki H, et al. Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells. J Invest Dermatol 2004 : 122 : 95 102.
31. Sarris AH, Broxmeyer HE, Wirthmueller U, et al. Human interferon-inducible protein 10: expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors. J Exp Med 1993 : 178 : 1127 1132.
32. Linehan MF, Frank TL, Hazell ML, et al. Is the prevalence of wheeze in children altered by neonatal BCG vaccination? J Allergy Clin Immunol 2007 : 119 : 1079 1085.